Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2025 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| TRANEXAMIC ACID INJECTION | eugia pharma inc. | Marketed | Nov 6, 2024 | Marketed |
| APIXABAN | sanis health inc | Marketed | Nov 6, 2024 | Marketed |
| BEYFORTUS | Sanofi Pasteur Limited | Marketed | Nov 4, 2024 | Marketed |
| EXCLUSIVE VIR-OUT DISINFECTANT CLEANER | EXCLUSIVE PRODUCTS INC. | Marketed | Nov 1, 2024 | Marketed |
| PUREROX | HSP USA, LLC | Marketed | Nov 1, 2024 | Marketed |
| JAMP SUMATRIPTAN | Jamp Pharma Corporation | Marketed | Nov 1, 2024 | Marketed |
| JAMP SUMATRIPTAN | Jamp Pharma Corporation | Marketed | Nov 1, 2024 | Marketed |
| JAMP SUMATRIPTAN | Jamp Pharma Corporation | Marketed | Nov 1, 2024 | Marketed |
| PANTOPRAZOLE | 10445517 canada inc / north pharmaceuticals / dac pharmaceuticals | Marketed | Nov 1, 2024 | Marketed |
| MINT-METFORMIN XR | mint pharmaceuticals inc | Marketed | Oct 31, 2024 | Marketed |
| FRUZAQLA | takeda canada inc | Marketed | Oct 30, 2024 | Marketed |
| FRUZAQLA | takeda canada inc | Marketed | Oct 30, 2024 | Marketed |
| NRA-BILASTINE | nora pharma inc | Marketed | Oct 30, 2024 | Marketed |
| APO-BILASTINE TABLETS | Apotex Inc | Marketed | Oct 29, 2024 | Marketed |
| PANTOPRAZOLE FOR INJECTION | eugia pharma inc. | Marketed | Oct 29, 2024 | Marketed |
| IXCHIQ | Valneva Austria GmbH | Marketed | Oct 28, 2024 | Marketed |
| NOYADA | Ethypharm Inc | Marketed | Oct 28, 2024 | Marketed |
| NOYADA | Ethypharm Inc | Marketed | Oct 28, 2024 | Marketed |
| NRA-PRUCALOPRIDE | nora pharma inc | Marketed | Oct 28, 2024 | Marketed |
| SANDOZ AFATINIB | Sandoz Canada, Inc. | Marketed | Oct 28, 2024 | Marketed |
